Genome‐Wide Association Analyses of HPV16 and HPV18 Seropositivity Identify Susceptibility Loci for Cervical Cancer
Journal of Medical Virology · 2025-02 · 97 (2)
DOI: 10.1002/jmv.70195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 31.01.2025. Verfasst von Theresa Beckhaus und 20 weiteren Autor:innen. Beteiligte Einrichtung: Gynaecology Research Unit, Department of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Human papillomavirus 16, Genetic Predisposition to Disease, Papillomavirus Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: D.R. and T.D. received funding from the H.W. & J. Hector Stiftung (M2414). D.R. received funding from the Tumorstiftung at Hannover Medical School. M.G. receiv….
Abstract (Originalsprache)
Infection by high‐risk human papillomavirus is known to exacerbate cervical cancer development. The host immune response is crucial in disease regression. Large‐scale genetic association studies for cervical cancer have identified few susceptibility variants, mainly at the human leukocyte antigen locus on chromosome 6. We hypothesized that the host immune response modifies cervical cancer risk and performed three genome‐wide association analyses for HPV16, HPV18 and HPV16/18 seropositivity in 7814, 7924, and 7924 samples from the UK Biobank, followed by validation genotyping in the German Cervigen case‐control series of cervical cancer and dysplasia. In GWAS analyses, we identified two loci associated with HPV16 seropositivity (6p21.32 and 15q26.2), two loci associated with HPV18 seropositivity (5q31.2 and 14q24.3), and one locus for HPV16 and/or HPV18 seropositivity (at 6p21.32). MAGMA gene‐based analysis identified HLA‐DQA1 and HLA‐DQB1 as genome‐wide significant (GWS) genes. In validation genotyping, the genome‐wide significant lead variant at 6p21.32, rs9272293 associated with overall cervical disease (OR = 0.86, p = 0.004, 95% CI = 0.78–0.95, n = 3710) and HPV16 positive invasive cancer (OR = 0.73, p = 0.005, 95% CI = 0.59–0.91, n = 1431). This variant was found to be a robust eQTL for HLA‐DRB1 , HLA‐DQB1‐AS1 , C4B , HLA‐DRB5 , HLA‐DRB6 , HLA‐DQB1 , and HLA‐DPB1 in a series of cervical epithelial tissue samples. We additionally genotyped twenty‐four HPV seropositivity variants below the GWS threshold out of which eleven variants were found to be associated with cervical disease in our cohort, suggesting that further seropositivity variants may determine cervical disease outcome. Our study identifies novel genomic risk loci that associate with HPV type‐specific cervical cancer and dysplasia risk and provides evidence for candidate genes at one of the risk loci.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gynaecology Research Unit, Department of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany.
- Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.
- Stanford Cancer Institute, Stanford School of Medicine, Stanford, California, USA.
- IZD Hannover, Hannover, Germany.
- Department of Gynaecology, Martin-Luther University, Halle-Wittenberg, Germany.
- Department of Gynaecology, Clinics Carl Gustav Carus, University of Dresden, Dresden, Germany.
ORCID-Profile: Linda Kachuri, Maya Geerts, Peter A Fasching, Norman Häfner, Matthias Jentschke, Peter Hillemanns, Tracy A O'Mara, Stephen S Francis, John S Witte, Thilo Dörk, Dhanya Ramachandran
Förderung
- D.R. and T.D. received funding from the H.W. & J. Hector Stiftung (M2414). D.R. received funding from the Tumorstiftung at Hannover Medical School. M.G. receiv…
Zitieren
APA
Beckhaus, T., Kachuri, L., Nakase, T., Schürmann, P., Eisenblätter, R., Geerts, M., Böhmer, G., Strauß, H. G., Hirchenhain, C., Schmidmayr, M., Müller, F., Fasching, P. A., Häfner, N., Luyten, A., Jentschke, M., Hillemanns, P., O'Mara, T. A., Francis, S. S., Witte, J. S., …, & Ramachandran, D. (2025). Genome‐Wide Association Analyses of HPV16 and HPV18 Seropositivity Identify Susceptibility Loci for Cervical Cancer. Journal of Medical Virology, 97(2). https://doi.org/10.1002/jmv.70195
Vancouver
Beckhaus T, Kachuri L, Nakase T, Schürmann P, Eisenblätter R, Geerts M, et al. Genome‐Wide Association Analyses of HPV16 and HPV18 Seropositivity Identify Susceptibility Loci for Cervical Cancer. Journal of Medical Virology. 2025;97(2). doi:10.1002/jmv.70195
BibTeX
@article{Beckhaus2025,
author = {Beckhaus, Theresa and Kachuri, Linda and Nakase, Taishi and Schürmann, Peter and Eisenblätter, Rieke and Geerts, Maya and Böhmer, Gerd and Strauß, Hans-Georg and Hirchenhain, Christine and Schmidmayr, Monika and Müller, Florian and Fasching, Peter A and Häfner, Norman and Luyten, Alexander and Jentschke, Matthias and Hillemanns, Peter and O'Mara, Tracy A and Francis, Stephen S and Witte, John S and Dörk, Thilo and Ramachandran, Dhanya},
title = {Genome‐Wide Association Analyses of HPV16 and HPV18 Seropositivity Identify Susceptibility Loci for Cervical Cancer},
journal = {Journal of Medical Virology},
year = {2025},
volume = {97},
number = {2},
doi = {10.1002/jmv.70195}
}
EUVIMED